Sonic Healthcare has acquired Dr Risch laboratory group in Switzerland, comprising 13 clinical laboratories in Switzerland and one in Vaduz, Liechtenstein.
In 2023, the facilities generated approximately CHF94 million ($162 million) in revenue.
The CHF117 million ($201.7 million) purchase price includes CHF30 million ($51.7 million) worth of Sonic Healthcare ordinary shares issued to the sellers, with the remainder funded in Swiss francs from Sonic’s existing cash and debt facilities.
The transaction, expected to close by March 31, is anticipated to boost earnings per share by 2025 and yield a return on invested capital.